Carnitine palmitoyltransferase 1A (CPT1A) is a one of the most crucial components in fatty acid metabolism, serving as the rate-limiting enzyme in the β-oxidation pathway, its deficiency can result in a range of metabolic disorders, including hypoketotic hypoglycemia, hepatomegaly, increased concentrations of circulating free fatty acid and the abnormal deposition of lipids within skeletal muscle tissue (48). Here, CPT1A is linked to Other metabolic disease.